Changes of biological features in breast cancer cells determined by primary chemotherapy
Antonio Frassoldati(Italian Oncology Group of Clinical Research), Vittorio Silingardi(University of Modena and Reggio Emilia), Maria Banzi(Azienda Ospedaliera S.Maria), L Piccinini(University of Modena and Reggio Emilia), Francesca Adami(Azienda Ospedaliera Carlo Poma), Mario Criscuolo(University of Modena and Reggio Emilia)
Cited by 40
Related Papers
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240